---
title: "A multi-part study to investigate MTX325 in healthy volunteers and patients with Parkinson's Disease"
euct_id: 2024-517310-15-00
phase: Phase 3
status: Not yet recruiting
sponsor: Mission Therapeutics Limited
canonical_url: "https://parkinsonspathways.com/trials/eu/2024-517310-15-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2024-517310-15-00"
ctis_last_updated: "2026-05-23T03:30:55.061466142"
source: EU Clinical Trials Information System (CTIS)
---
# A multi-part study to investigate MTX325 in healthy volunteers and patients with Parkinson's Disease

**EU CT Number:** [2024-517310-15-00](https://euclinicaltrials.eu/ctis-public/view/2024-517310-15-00)

## Key Facts

- **Phase:** Phase 3
- **Status:** Not yet recruiting
- **Sponsor:** Mission Therapeutics Limited
- **Start Date:** 2026-06-30
- **Completion Date:** 2027-06-02
- **Conditions:** Parkinson's Disease

## Member States

Trial is authorized in 3 member states: France, Germany, Netherlands.

## Sites (8)

- Technische Universitaet Dresden, Dresden, Germany
- LMU Klinikum Muenchen AöR, Munich, Germany
- Universitaetsklinikum Duesseldorf AöR, Duesseldorf, Germany
- Centre for Human Drug Research, Leiden, Netherlands
- Centre Hospitalier Universitaire De Lille, Lille, France
- Centre Hospitalier Universitaire De Toulouse, Toulouse, France
- Hospices Civils De Lyon, Bron, France
- Assistance Publique Hopitaux De Paris, Paris Cedex 13, France

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Parkinson's Disease
Age groups: elderly 65+, adults 18-64
Sex: male, female
Includes a vulnerable population.
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2024-517310-15-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2024-517310-15-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2024-517310-15-00*